Crohn's Disease Treatment Market To Surpass US$ 10 Billion By 2025 - Coherent Market Insights

1. CROHN'S DISEASE TREATMENT MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Crohn’s Disease Treatment Market - Overview The global Crohn’s Disease Treatment Market, by Drug Type (Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators & Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacy and e-Commerce), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 9.4 billion in 2017 and is projected to exhibit a CAGR of 4.3% over the forecast period (2018 – 2026). Crohn’s Disease Treatment market is expected to gain significant traction over the forecast period, owing to increasing number of patients suffering from gastrointestinal tract diseases. According to the Centers of Disease Control and Prevention, in 2016, approximately 34 million Americans were reported to be afflicted from diseases of the digestive system. North America and Europe to dominate Crohn’s disease treatment market owing to high incidence and prevalence of the disease The North America and Canada collectively has the highest incidence and prevalence rates of inflammatory bowel disease and Crohn’s disease in the world. According to a study published in the Lancet in October, 2017, around 319 and 322 cases of Crohn’s disease per 1, 00,000 people were reported in the U.S. and Europe respectively. Moreover, according to the Crohn’s and Colitis Foundation, approximately 1.6 million Americans were reported with inflammatory bowel disease in 2011 and around 70,000 new cases are diagnosed each year. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/crohns- disease-treatment-market-1237 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION For instance, in 2017, the U.S. FDA granted approval Cyltezo, developed by Boehringer Ingelheim International GmbH, which is a biosimilar to Humira, for the treatment of Crohn’s disease and ulcerative colitis. Moreover, Pfizer, Inc. also received approval for another therapy Ifixi which is a monoclonal antibody biosimilar to Janssen’s Remicade for the treatment of Crohn’s disease. Browse 34 Market Data Tables and 38 Figures spread through 150 Pages and in-depth TOC on “Crohn’s Disease Treatment Market”- by Drug Type (Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators & Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacy and e-Commerce), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026 Crohn’s disease treatment market is expected to exhibit significant growth, owing to increasing new product launches by key players as well as a large number of drugs completing successful clinical trial phases to receive market approvals. For instance, in September 2016, Johnson & Johnson received FDA approval for the company’s blockbuster drug Stelara for use in adults indicated in treatment of Crohn’s disease in the U.S. In April 2018, Qu Biologics, a Vancouver Canada based biopharmaceutical manufacturer successfully passed through the Phase I clinical trials of FDA and initiated Phase II studies for development of site specific Immunomodulators for the treatment of Crohn’s disease. Additionally, rising initiatives to spread awareness and conduct educational campaigns undertaken various organizations is also expected to support the market growth in the forecast years. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/1237 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Key Takeaways of Crohn’s Disease Treatment Market: The global Crohn’s disease treatment market is expected to exhibit a CAGR of 4.3% during the forecast period, owing to increasing number patients suffering with inflammatory bowel disease Among drug type, immunomodulators segment holds a dominant position in global Crohn’s disease treatment market, owing to their better therapeutic action Among distribution channel, hospital pharmacies segment is expected to dominate the global Crohn’s disease treatment market, owing to rising number of patients visiting hospitals for consultation of treatment associated with the disease North America is expected to dominate the global Crohn’s disease treatment market, owing to introduction of innovative solutions in market coupled with presence of leading market players in the region The key players operating in global Crohn’s disease treatment market include AbbVie Inc., Janssen Biotech, Inc., Allergan Inc., Bayer AG, Bristol-Myers Squibb, Pfizer, Inc., Boehringer Ingelheim GmbH, F. Hoffmann-La Roche, Eli Lilly and Company, GlaxoSmithKline plc, Novartis International AG, Sanofi S.A Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1237 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved